Home » LATEST RESEARCH FINDINGS INDICATE THAT DRUG ELUTING STENTS (DES) REDUCE THE NEED FOR RE-INTERVENTION AFTER PTCA TO A GREATER EXTENT THAN BARE METAL STENTS (BMS)
LATEST RESEARCH FINDINGS INDICATE THAT DRUG ELUTING STENTS (DES) REDUCE THE NEED FOR RE-INTERVENTION AFTER PTCA TO A GREATER EXTENT THAN BARE METAL STENTS (BMS)
Research and Markets has announced the addition of Drug Eluting Stents Technology
& Market Forecast to their offering The introduction of Drug Eluting Stents
has dramatically impacted the market size and growth rates for coronary stents
worldwide. It has also impacted the distribution of market shares across the
industry.
Genetic
Engineering News
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May